CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Nebivolol +1 moredrug
Likely dose
Nebivolol 2.5 mg daily or Atenolol 25 mg dailyAI-extracted
Key inclusion· 2
  • ✓Age 18 years or older
  • ✓Blood pressure <140/85 mmHg on a maximum of two anti-hypertensive drugs
Key exclusion· 10
  • ✕History of asthma
  • ✕History of diabetes
  • ✕History of heart failure
  • ✕History of bradycardia

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00125853
NCT00125853N/ACompleted
CompareCT.gov

A Trial to Compare the Effects of Nebivolol Versus Atenolol on Various Cardiovascular Measurements Including Insulin Sensitivity

Imperial College London·interventional·Posted Aug 2, 2005·Updated Dec 12, 2019

In Brief

A clinical study evaluating Nebivolol and Atenolol for Hypertension. Completed, enrolled 54 participants across 1 site.

Detailed Summary

The purpose of this study is to conduct a randomised trial to compare the insulin sensitivity, 24 hour blood pressure profile, and tolerability of nebivolol plus a thiazide-like diuretic versus atenolol plus a thiazide-like diuretic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited Kingdom
CollaboratorsFoundation for Circulatory Health

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 2, 2005
Enrollment StartJul 1, 2006
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 20.9 years ago

Interventions

Nebivololdrug

Nebivolol 2.5mg daily

Atenololdrug

Atenolol 25mg daily